Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring : recommendations for a public health approach / World Health Organization.

Format:

Book

Author/Creator:

World Health Organization, author, issuing body.

Language:

English

Subjects (All):

Antiretroviral agents.

HIV infections--Prevention.

HIV infections.

Physical Description:

1 online resource (xlii, 548 pages) : illustrations

Edition:

1st ed.

Other Title:

Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring

Place of Publication:

Geneva : World Health Organization, [2021]

Contents:

Foreword

Abbreviations and acronyms

ACKNOWLEDGEMENTS

Executive summary

Summary recommendations

INTRODUCTION

1.1 Background and rationale

1.2 Objectives

1.3 Target audience

1.4 Guiding principles

1.5 Methods for developing the guidelines

1.6 Organization of the guidelines

HIV TESTING AND DIAGNOSIS

2.1 Introduction

2.2 HIV testing for a changing epidemic

2.3 Mobilizing demand and pre-test services

2.4 HIV testing service delivery approaches

2.5 Post-test services and linkage to prevention, treatment and other services

2.6 Strategies to make HIV testing services accessible

2.7 Maintaining the accuracy and reliability of HIV diagnosis

2.8 HIV diagnosis among infants and children

HIV prevention

3.1 Combination HIV prevention

3.2 Pre-exposure prophylaxis for preventing the acquisition of HIV

3.3 Post-exposure prophylaxis

3.4 Infant prophylaxis

ANTIRETROVIRAL THERAPY

4.1 Introduction

4.2 Preparing people living with HIV for ART

4.3 What to expect in the first months of ART

4.4 When to start ART

4.5 Timing of ART

4.6 What to start

4.7 Monitoring the response to ART

4.8 Monitoring ARV toxicity

4.9 ARV drug resistance

4.10 Key ARV drug interactions

Managing advancedHIV disease

5.1 Introduction

5.2 Causes of morbidity and mortality among adults with advanced HIV disease

5.3 Providing a package of care

5.4 Overview of clinical management of cryptococcal disease

5.5 Overview of clinical management of histoplasmosis

5.6 Advanced HIV disease among children and adolescents

5.7 Supporting decision-making for providing a packageof care

5.8 Programme considerations

GENERAL CARE AND MANAGING COMMON COINFECTIONS AND COMORBIDITIES

6.1 Introduction

6.2 General care for people living with HIV

6.3 Co-trimoxazole prophylaxis.

6.4 Tuberculosis

6.5 Hepatitis B and C

6.6 Malaria

6.7 Buruli ulcer

6.8 Leishmaniasis

6.9 Cervical cancer

6.10 Noncommunicable diseases

6.11 Mental health among people living with HIV

6.12 Drug use

6.13 Sexually transmitted infections

6.14 Vaccines for people living with HIV

6.15 HIV-related skin and oral conditions

6.16 Nutritional care and support

6.17 Palliative care

6.18 Noncommunicable diseases among children and adolescents

SERVICE DELIVERY

7.1 Introduction

7.2 Linkage from HIV testing to enrolment in care

7.3 Differentiated service delivery for HIV treatment

7.4 People-centred care

7.5 Initiating and maintaining treatment

7.6 Continuity of care

7.7 Task sharing

7.8 Decentralization

7.9 Integrating services

7.10 Delivering HIV services to children

7.11 Service delivery for adolescents

7.12 Improving the quality of HIV care services

7.13 Procurement and supply management systems for HIV health products

7.14 Laboratory and diagnostic services

7.15 Laboratory connectivity

MONITORING ART PROGRAMME FUNCTIONING

8.1 Introduction

8.2 Selection of key indicators to improve service delivery and assess impact

8.3 Data collection and disaggregation

8.4 Strengthening data systems

8.5 Evaluation, including impact and programme performance

8.6 Monitoring ARV drug toxicity

8.7 HIV drug resistance

Publication, dissemination and evaluation

9.1 Publication

9.2 Dissemination and implementation

9.3 Useful analytical tools for planning

9.4 Evaluation

Glossary

ANNEX 1: DOSAGES FOR ARV DRUGS

Annex 2: key drug interactions

for aRVs

1.6 Organization of the guidelines.

2.1 Introduction

6.3 Co-trimoxazole prophylaxis

6.4 Tuberculosis

6.18 Noncommunicable diseases among children and adolescents.

7.1 Introduction

Foreword

Executive summary.

Notes:

Description based on: online resource; title from PDF title page (NCBI, viewed November 3, 2022).

Includes bibliographical references.